To determine the association of the Ras-MEK-ERK pathway with NB prognosis, we investigated the correlation of RAF1 and MAP2K2 gene expression levels with overall NB patient outcomes by analyzing a total of 1235 primary NB patient clinical data. The gene discussed is MAPK1; the disease is neuroblastoma.